Antifungal susceptibility testing of dermatophytes: Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates

Journal of Clinical Microbiology

Volumn 38, Issue 1, 2000, Pages 341-344

  Jessup, C J ^a   Warner, J ^a   Isham, N ^a   Hasan, I ^a   Ghannoum, M A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; FLUCONAZOLE; GLUCOSE; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CULTURE MEDIUM; DERMATOPHYTE; FUNGUS CULTURE; FUNGUS GROWTH; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OAT; POTATO; PRIORITY JOURNAL; RICE; STANDARD; TEMPERATURE; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CULTURE MEDIA; EPIDERMOPHYTON; MICROBIAL SENSITIVITY TESTS; MICROSPORUM; SPORES, FUNGAL; TIME FACTORS; TRICHOPHYTON;

EID: 0033988169     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Elewski, B. E. and M. A. Charif. 1997. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch. Dermatol. 133:1172-1173.
2. Espinel-Ingroff, A., K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, V. Paetznick, J. Peter, M. Rinaldi, and T. Walsh. 1995. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing of filamentous fungi. Antimicrob. Agents Chemother. 39: 314-319.
3. Georg, L. K., and L. B. Camp. 1956. Routine nutritional tests for the identification of dermatophytes. J. Bacteriol. 74:113-121.
4. Ghannoum, M. A. 1997. Susceptibility testing of fungi and correlation with clinical outcome. J. Chemother. 9(Suppl. 1):19-24.
5. Jesenska, Z. 1979. Comparative study of the growth inhibition of vegetative hyphae of some dermatophytes and keratinophilic fungi on glucose-peptoneagar with griseofulvin. Dermatol. Monatsschr. 165:292-299.
6. Larone, D. H. 1995. Medically important fungi: a guide to identification, 3rd ed. ASM Press, Washington, D.C.
7. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. Norris, H. A., B. E. Elewski, and M. A. Ghannoum. 1999. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J. Am. Acad. Dermatol. 40(6, part 2):S9-S13.
9. Odds, F. C., F. Van Gerven, A. Espinel-Ingroff, M. S. Bartlett, M. A. Ghannoum, M. V. Lancaster, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, and T. J. Walsh. 1998. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob. Agents Chemother. 42:282-288.
10. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, et al. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole and Candida infections. Clin. Infect. Dis. 24:235-247.
11. Ryder, N. S., and B. Favre. 1997. Antifungal activity and mechanism of action of terbinafine. Rev. Contemp. Pharmacother. 8:275-287.
12. Weitzman, I., and R. C. Summerbell. 1995. The dermatophytes. Clin. Microbiol. Rev. 8:240-259.